Global Medical Device Regulation: Emphasis on Active Implants: Usfda, Emea and Anvisa - Bhuvan P. Raval - Books - LAP LAMBERT Academic Publishing - 9783659445736 - August 16, 2013
In case cover and title do not match, the title is correct

Global Medical Device Regulation: Emphasis on Active Implants: Usfda, Emea and Anvisa

Bhuvan P. Raval

Price
¥ 8,817
excl. VAT

Ordered from remote warehouse

Expected delivery Oct 20 - 30
Add to your iMusic wish list

Global Medical Device Regulation: Emphasis on Active Implants: Usfda, Emea and Anvisa

Regulations for medical devices in EU Member countries are governed by European Medicine Evaluation Authority, popularly known as EMEA. As per EMEA's guideline each member country has to strictly follow the common guidelines with exception to rules and regulation that are modified by state authorities but must be in conformity with EMEA Guideline. Regulations posed in here are further divided in implantable and active implantable medical devices thereafter where manufacturing, testing and distribution can only be done once it is CE marked. In case of non CE marked devices i.e. non-EU member manufacturer, market authorisation process shall be completed prior to approval and separately. For brazil market that is governed by ANVISA, medical devices are classified into four different classes. There is no independent discrimination made for Active implantable medical devices but most non invasive devices are covered in Class I. While those which are to be connected with blood storage and other devices are classified into class II. Class III devices are those which are connected or included with wounds or healthy tissues.

Media Books     Paperback Book   (Book with soft cover and glued back)
Released August 16, 2013
ISBN13 9783659445736
Publishers LAP LAMBERT Academic Publishing
Pages 144
Dimensions 150 × 9 × 226 mm   ·   233 g
Language German  

Show all

More by Bhuvan P. Raval